Welcome to our dedicated page for Zepp Health Corporation news (Ticker: ZEPP), a resource for investors and traders seeking the latest updates and insights on Zepp Health Corporation stock.
Zepp Health Corporation (NYSE: ZEPP) is a leading global provider of smart wearables and health technology solutions that enable users to maximize their health, fitness, and wellness. Established in 2013 as Huami Corp., the company rebranded to Zepp Health in February 2021 to emphasize its health-centered approach. Zepp Health is renowned for its innovative brands such as Amazfit, Zepp Clarity, and Zepp Aura, which together form a comprehensive ecosystem empowering users to achieve their wellness goals.
Central to Zepp Health's offerings is the proprietary Zepp Digital Health Management Platform, which integrates advanced technologies including Zepp OS, AI chips, biometric sensors, and sophisticated data algorithms. This platform provides 24/7 actionable insights and guidance, supporting users in their everyday health and fitness journeys. To date, Zepp Health has shipped over 200 million units, with its products accessible in more than 90 countries worldwide.
Zepp Health's product portfolio is diverse, featuring smartwatches, fitness bands, and innovative devices like the Amazfit Helio Ring and Amazfit Bip 5 Unity. The company's products are designed to offer a perfect blend of style and cutting-edge technology, appealing to both professional athletes and everyday fitness enthusiasts. Notably, the Amazfit brand has garnered numerous design accolades, including the iF Design Award and the Red Dot Design Award.
Recent achievements highlight Zepp Health's commitment to excellence and community. The company has been actively involved in significant partnerships, such as sponsoring the NN Rotterdam Marathon and the Escape from Alcatraz Triathlon. Through these partnerships, Zepp Health not only promotes its high-performance wearables but also supports athletic communities worldwide.
Financially, Zepp Health reported revenues of US$39.8 million for the first quarter of 2024, with a gross margin of 36.8%. Despite a challenging market, the company's self-branded products have shown robust performance, contributing significantly to its revenue. Looking forward, Zepp Health continues to expand its product offerings and invest in strategic marketing initiatives, ensuring sustained growth and innovation.
Zepp Health's commitment to advancing health technology is further exemplified by its partnership with LiveX AI to enhance customer experiences on the Amazfit website. This collaboration utilizes AI to provide personalized and efficient customer support, setting a new standard in the industry.
For more information about Zepp Health Corporation and its innovative health technology solutions, visit www.zepp.com.
Zepp Health Corp. (NYSE: ZEPP) announced that it will release its fourth quarter and full year 2021 financial results on March 17, 2022, before market open. A conference call will follow at 8:00 a.m. ET the same day, accessible via various dialing options. The company, established in 2013, specializes in smart health technology, shipping 46 million units in 2020, including 33 million smart watches. Zepp Health aims to connect health with technology through proprietary AI chips, biometric sensors, and operating systems.
Amazfit, a brand of Zepp Health (NYSE: ZEPP), has launched a Valentine's Day gift guide featuring smart wearables designed to enhance health and connection. The guide highlights products such as the Amazfit GTR 3, GTS 3, and Bip U Series, all emphasizing heart rate monitoring and health management. An exclusive Valentine's Day Sale offers discounts up to 36%, running from January 26 to February 14, 2022, across various countries. The brand encourages customer engagement through social media activities, promising exciting prizes. For more details, visit their official website.
Zepp Health (NYSE: ZEPP) released its 2021 Reports on User Health Status, analyzing data from over 30 million users across five countries. Key findings reveal that exercise patterns have not fully recovered post-pandemic, with notable declines in daily sleep and increases in stress levels. The reports highlight that only 33.3% of US users are within the standard BMI range, while Chinese users exhibit the highest percentage at 57.5%. The analysis indicates a correlation between sleep duration, stress levels, and overall health, stressing the need for improved self-care and physical activity.
Viant Technology Inc. (NASDAQ: DSP) has appointed Brad Samson as Vice President of Investor Relations. With over 30 years of experience, Samson will oversee Viant's investor relations strategy and stakeholder relationships. He previously worked with companies like Zepp Health and Fitbit. Chief Financial Officer Larry Madden expressed excitement about Samson's appointment, emphasizing his capability to enhance communications regarding strategy and growth opportunities. This move is expected to strengthen Viant's position within the advertising software industry.
Zepp Health Corp. (NYSE: ZEPP) has announced an event on January 5, 2022, at 8:00 a.m. PT, aimed at discussing the role of data from smart wearables in healthcare. Industry leaders, including Zepp's CEO Wayne Huang and experts from reputable organizations, will share insights and engage in Q&A sessions. The event will be streamed live on LinkedIn, requiring prior registration. Zepp Health, based in Hefei, China, is a leading developer of smart health technology and shipped 46 million units, including 33 million smart watches, in 2020.
Zepp Health Corp. (NYSE: ZEPP) has revised its Q4 2021 revenue guidance to between RMB1.6 billion and RMB1.75 billion, down from a previous estimate of RMB1.75 billion to RMB2.0 billion. Contributing factors include ongoing Covid impacts, a global chip shortage, and heightened restrictions in Europe. Despite this, the company anticipates maintaining profitability. Additionally, Zepp Health has initiated a share repurchase program with an authorization of up to US$20 million, having already repurchased approximately US$3.6 million in stock.
Zepp Health Corp. (NYSE: ZEPP) will host a LinkedIn Live event on January 5, 2022, at 8:00 a.m. Pacific Time, focusing on the use of data in healthcare through wearable technology. Key speakers include the company’s CEO, experts from IDC, HIMSS, ONC, and researchers from Norwegian University of Science and Technology, Stanford, and Peking University. The session will feature presentations followed by a Q&A segment. Interested participants need to register via Zepp Health’s LinkedIn page to join the event.
Zepp Health (NYSE: ZEPP) reported strong growth in adult watch shipments for Q3 2021, outperforming the overall market. According to IDC, Zepp’s brands, Amazfit and Zepp, showed the highest growth among top competitors. The company dominated markets in Brazil, the Czech Republic, Russia, and Indonesia, with over 30% market share in Brazil and the Czech Republic. Zepp Health ranked third in Mexico and fourth in Germany, South Korea, and Japan. Additionally, Amazfit's smartwatches excelled during Black Friday sales, with top rankings on Amazon. Holiday promotions are underway to capitalize on rising health awareness among consumers.
Amazfit, a brand of Zepp Health (NYSE: ZEPP), ranked third globally in smartwatch shipments in Q3 2021, with 9.9 million units shipped, marking an 89% year-over-year growth. Total shipments reached 27.8 million in the first nine months of 2021. Notably, 61.8% of shipments occurred overseas, with significant sales increases in Italy, Spain, Germany (+150%), and Turkey (+324%). The brand's success follows the launch of new models and a strong promotional push. Upcoming festive sales are also expected to boost annual revenue.
Zepp Health Corporation (NYSE: ZEPP) reported third-quarter revenue of RMB 1.61 billion (US$249.3 million), down 28.1% year-over-year, due to decreased sales of Xiaomi wearable products. Unit shipments decreased 37.7% to 9.9 million, but Amazfit and Zepp product shipments rose 88.9%. The company maintained a gross margin of 20.2% and reduced operating expenses by 31.2%. A $20 million share repurchase program was approved, indicating management's confidence in the company's long-term strategy and strong cash position. Q4 revenue guidance is projected between RMB 1.75 billion and RMB 2.0 billion.